Innate Immune Dysregulations and Cross Talk in COVID-19: Novel Players in Atherogenesis

Arterioscler Thromb Vasc Biol. 2024 Oct;44(10):2223-2225. doi: 10.1161/ATVBAHA.124.321415. Epub 2024 Aug 8.

Authors

Natalia Eberhardt¹, Chiara Giannarelli^{1

2}

Affiliations

¹ Department of Medicine, Division of Cardiology, New York University Cardiovascular Research Center, New York University Grossman School of Medicine, New York (N.E., C.G.).
² Department of Pathology, New York University Grossman School of Medicine, New York (C.G.).

PMID: 39114915
PMCID: PMC11424251 (available on 2025-10-01)
DOI: 10.1161/ATVBAHA.124.321415

No abstract available

Keywords: COVID-19; Editorials; atherosclerosis; inflammation; killer cells, natural.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Animals
Atherosclerosis* / immunology
COVID-19* / immunology
Humans
Immunity, Innate*
SARS-CoV-2* / immunology
SARS-CoV-2* / pathogenicity

Grants and funding